The Johnson & Johnson Vaccine Pause and the Media’s Role in Communicating Risk

Posted

Early yesterday, the Food and Drug Administration and the Centers for Disease Control and Prevention recommended that the US pause distribution of Johnson & Johnson’s coronavirus vaccine following reports of blood clotting in six recipients, all of them women aged between eighteen and forty-eight, one of whom has died and another of whom is critically ill.

Click here to read more. 

Comments

No comments on this story | Please log in to comment by clicking here
Please log in or register to add your comment

Media Virus Watch logo